Back

Current status of antiarrhythmic therapy in atrial fibrillation

31 March 2025 (16:45 - 17:00)
Organised by: Logo
Congress Presentation Part of: Update on antiarrhythmic therapy Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Babak Nazer

University of Washington, Seattle (United States of America)

3 More presentations in this session

Presentation thumbnail
Antiarrhythmic therapy in pregnancy
Doctor A. Perez-Silva (Concepcion, CL)
Slides Video
Presentation thumbnail
Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation
Professor N. Jost (Szeged, HU)
Slides Video
Presentation thumbnail
Targeting atrial myopathy: is this the future of pharmacological rhythm control in atrial fibrillation?
Professor B. Brundel (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
Update on antiarrhythmic therapy
Video

The Event

Event poster

EHRA 2025

31 March 2025 16:45 CET
You may be interested in
thumbnail
Congress Presentation
New AADs: what's in the pipeline?
30 March 2025
thumbnail
Congress Presentation
Atrial fibrillation (AF) clinical cases with focus on rhythm control and anticoagulation - discussion.
3 April 2022
thumbnail
Congress Presentation
Practical guide to antiarrhythmic drug therapy
31 August 2024
thumbnail
Congress Presentation
Misconceptions around antiarrhythmic drug therapy in AF and HF
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources